使用主成分分析预测肝细胞癌经动脉化疗栓塞术后的肿瘤反应
本概念验证研究回顾性分析2017年3月至7月间25例患者27个原发性肝细胞癌肿瘤的经动脉化疗栓塞术(TACE)数字减影血管造影(DSA)图像,结合主成分分析(PCA)将时空信息压缩为单幅图像,量化肿瘤染色并计算血管增强值(VEV)。结果显示治疗有效组(12个肿瘤)VEV均值0.96±0.455,无效组(15个肿瘤)为0.57±0.309,差异有统计学意义(p=0.013),提示肿瘤染色强度与治疗反应相关。
要点
- PCA可基于常规DSA图像量化肝细胞癌TACE术中的肿瘤染色。
- 治疗有效组VEV为0.96±0.455,无效组为0.57±0.309,p=0.013。
- 该先导研究提示肿瘤染色强度与TACE治疗反应相关。
核心结论
- 使用常规血管造影图像量化肿瘤染色的方法可行,计算出的VEV可能有助于预测肿瘤对TACE的治疗反应;该先导研究表明肿瘤染色强度与治疗反应之间存在相关性。
研究设计与样本
- 概念验证研究,回顾性分析2017年3月至7月间进行的TACE手术,纳入25例患者(18男,7女;平均年龄66岁±9)的27个原发性肝细胞癌肿瘤,将DSA与PCA结合以压缩时空信息为单幅图像,术后1个月评估肿瘤治疗反应。
关键影像表现/征象
- PCA生成的透视成像(PCA-FI)可量化肿瘤染色并为每个肿瘤分配血管增强值(VEV)。
- 治疗有效组肿瘤(N=12)VEV均值0.96±0.455,无效组肿瘤(N=15)VEV均值0.57±0.309,有效组高于无效组(p=0.013)。
诊断标准与关键数值
- 通过计算肿瘤与肝脏的对比增强并取比值来确定肿瘤的相对血管增强。
- 血管增强值(VEV)用于量化肿瘤染色,治疗后1个月评估肿瘤反应。
临床应用与阅片要点
- 作者认为,使用常规血管造影图像计算出的VEV可能有助于预测TACE治疗反应。
- 该先导研究提示肿瘤染色强度与肿瘤治疗反应之间存在相关性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To quantitate the tumor blush of hepatocellular carcinoma (HCC) at the time of transarterial chemoembolization (TACE) using principal component analysis (PCA), and to correlate the quantitated tumor blush to response to therapy.
MATERIALS AND METHODS: In this proof-of-concept study, 27 primary HCC tumors in 25 patients (18 men, 7 women; mean age 66 years ± 9) were analyzed. We conducted a retrospective analysis of TACE procedures that were performed during March through July of 2017. Digital subtraction angiography (DSA) was combined with PCA to condense spatial and temporal information into a single image. The tumor and liver contrast enhancements were calculated, and the ratio was used to determine the relative vascular enhancement of the tumor. Tumor response to therapy was determined at 1-month post procedure.
RESULTS: Using PCA-generated fluoroscopic imaging (PCA-FI), we quantitated the tumor blush and assigned a vascular enhancement value (VEV) to each tumor. Tumors that responded to treatment (N = 12) had statistically higher VEVs compared with the nonresponders (N = 15), with a mean value of 0.96 ± 0.455 vs. 0.57 ± 0.309, (p = 0.013).
CONCLUSIONS: We developed a method for quantitating tumor blush using routine angiographic images. The VEVs calculated using these images may allow for the prediction of tumor response to therapy. This pilot study suggests that there is a correlation between tumor blush intensity and tumor response.
引用
- Miller JP, Ramaswamy R, Akinwande O, et al. Using principal component analysis for the prediction of tumor response to transarterial chemoembolization. Abdom Radiol (NY). 2019. PMID: 31004201. doi:10.1007/s00261-019-01982-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。